Mr. Page is a coinventor of the InnovaPrep concentration process and the technologies and processes that have been spurred since the initial development. He has a significant background in the field of Bioterrorism defense with nearly fifteen years experience working with aerosol collection, liquid-to-liquid concentration, and integration of these systems withdetector/identifiers.

Mr. Page has a broad, multidisciplinary science background that was cultivated while spending nearly 8 years at Midwest Research Institute (MRI) in Kansas City, Missouri as part of the Applied Engineering Division. MRI is an esteemed, independent, not-for-profit, contract research organization founded in 1944. While at MRI he served as principal investigator (PI) on a number of multidisciplinary programs; spending a significant period of time working on biodefense projects, and specifically in aerosol collect/detect systems for several classified government programs, such as the Department of Defense, and the U.S. Postal Service.

He holds twelve patents and pending patents in the areas of particle collection and concentration.

Andy Page  is currently President & CTO,  a member of the Board of Directors, and part owner of InnovaPrep LLC.